Annual report pursuant to Section 13 and 15(d)

Acquisitions - Narrative (Details)

v3.20.1
Acquisitions - Narrative (Details)
 12 Months Ended 15 Months Ended 39 Months Ended 63 Months Ended
Dec. 31, 2019
USD ($)
Sep. 25, 2018
shares
Sep. 24, 2018
USD ($)
therapy
milestone
shares
Feb. 16, 2018
USD ($)
Nov. 17, 2017
USD ($)
shares
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2023
USD ($)
Jun. 30, 2019
USD ($)
Jun. 29, 2019
USD ($)
Jun. 30, 2018
USD ($)
Dec. 31, 2017
USD ($)
Business Acquisition [Line Items]                            
Leased asset obtained in exchange for new operating lease liability             $ 19,971,554              
Useful life (in years)           1 year 10 months 21 days 2 years 10 months 17 days              
Debt assumed in Avadel Pediatric Products acquisition $ 0         $ 0 $ 15,075,000 $ 0            
Contingent consideration 0         0   0            
Goodwill 14,409,088         14,409,088 14,409,088 14,409,088           $ 12,290,247
Impairment of intangible assets           1,449,121 1,861,562              
Inventory, net 21,334         21,334 317,923 21,334            
Change in inventory reserve           36,577 $ 174,944              
Avadel                            
Business Acquisition [Line Items]                            
Cash       $ 1                    
Debt assumed in Avadel Pediatric Products acquisition       15,075,000                    
Contingent consideration 0     7,900,000   0   0            
Goodwill       $ 3,778,001                    
Goodwill tax deductible period       15 years                    
Fair value assigned to intangible asset at purchase       $ 18,291,000                    
TRx                            
Business Acquisition [Line Items]                            
Cash         $ 18,900,000                  
Contingent consideration 0       1,366,633 $ 0   0            
Goodwill         12,633,122                  
Fair value assigned to intangible asset at purchase         $ 19,596,000                  
Unregistered shares of common stock issued or issuable as part of acquisition (in shares) | shares         7,534,884                  
Shares issued for purchase of business (in shares)         $ 8,514,419                  
Shares issued upon closing (in shares) | shares         5,184,920                  
Contingent shares issuable as part of acquisition (in shares) | shares         2,349,968                  
Goodwill, expected tax deductible amount         $ 8,700,000                  
Acquired Assembled Workforce                            
Business Acquisition [Line Items]                            
Useful life (in years)           9 months 1 year 9 months              
PAI Sales & Marketing Agreement                            
Business Acquisition [Line Items]                            
Fair value of sales and marketing agreement                         $ 0  
PAI Sales & Marketing Agreement | TRx                            
Business Acquisition [Line Items]                            
Fair value assigned to intangible asset at purchase         2,553,000                  
Flexichamber                            
Business Acquisition [Line Items]                            
Inventory, net                     $ 0      
Change in inventory reserve           $ 200,000                
Flexichamber | Acquired Developed Technology | Avadel                            
Business Acquisition [Line Items]                            
Fair value assigned to intangible asset at purchase       $ 1,677,000             $ 0 $ 1,400,000    
Impairment of intangible assets           1,400,000                
Nonrecurring | Level 3 | PAI Sales & Marketing Agreement | TRx                            
Business Acquisition [Line Items]                            
Fair value of sales and marketing agreement 0         $ 0   0            
Ichorion                            
Business Acquisition [Line Items]                            
Consideration issued (in shares) | shares   5,800,000 5,800,000                      
Contingent consideration     $ 15,000,000                      
Leased asset obtained in exchange for new operating lease liability     20,000,000                      
Intangible assets     18,700,000                      
Cash acquired     $ 1,600,000                      
Number of preclinical therapies | therapy     3                      
Transaction costs     $ 200,000                      
Number of contingent consideration milestones | milestone     3                      
Payment for contingent consideration $ 0             $ 0            
Ichorion | Acquired Assembled Workforce                            
Business Acquisition [Line Items]                            
Intangible assets     $ 200,000                      
Useful life (in years)     2 years                      
Milestone One | TRx                            
Business Acquisition [Line Items]                            
Contingent consideration         3,000,000   $ 0              
Milestone Two | TRx                            
Business Acquisition [Line Items]                            
Contingent consideration         2,000,000                  
Milestone Three | TRx                            
Business Acquisition [Line Items]                            
Contingent consideration         $ 2,000,000                  
Scenario, Forecast | Milestone One | Ichorion                            
Business Acquisition [Line Items]                            
Payment for contingent consideration                 $ 6,000,000          
Scenario, Forecast | Milestone Two | Ichorion                            
Business Acquisition [Line Items]                            
Payment for contingent consideration                 5,000,000          
Scenario, Forecast | Milestone Three | Ichorion                            
Business Acquisition [Line Items]                            
Payment for contingent consideration                 $ 4,000,000 $ 4,000,000